Ivacaftor and Pneumonia - a phase IV clinical study of FDA data

Summary:

Pneumonia is reported as a side effect among people who take Ivacaftor (ivacaftor), especially for people who are female, 30-39 old, also take Pulmozyme, and have Cystic fibrosis.

The phase IV clinical study analyzes which people have Pneumonia when taking Ivacaftor. It is created by eHealthMe based on reports of 363 people who have side effects when taking Ivacaftor from the FDA, and is updated regularly.

What is Ivacaftor?

Ivacaftor has active ingredients of ivacaftor. eHealthMe is studying from 363 Ivacaftor users. Check the latest studies of Ivacaftor.

What is Pneumonia?

Pneumonia is found to be associated with 3,353 drugs and 4,681 conditions by eHealthMe. Check the latest studies of Pneumonia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

363 people reported to have side effects when taking Ivacaftor.
Among them, 20 people (5.51%) have Pneumonia.

Among these 20 people:

What is the gender of people who have Pneumonia when taking Ivacaftor? *

female: 75 %
male: 25 %

What is the age of people who have Pneumonia when taking Ivacaftor? *

What are other drugs people take besides Ivacaftor? *

What are other side effects people have besides Pneumonia? *

Infective Pulmonary Exacerbation Of Cystic Fibrosis (severe infective lung disease with production of abnormally thick mucus): 7 people, 35.00%
Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 5.00%
Acute Kidney Failure: 1 person, 5.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 5.00%
Blood Creatinine Increased: 1 person, 5.00%
Blood Iron Decreased: 1 person, 5.00%
Chest Pain: 1 person, 5.00%
Costochondritis (chest wall pain): 1 person, 5.00%
Coughing Up Blood: 1 person, 5.00%
Death: 1 person, 5.00%

What are the existing conditions these people have? *

Cystic Fibrosis (disease of the secretary glands): 20 people, 100.00%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 1 person, 5.00%
Pancreatic Insufficiency: 1 person, 5.00%
Nausea And Vomiting: 1 person, 5.00%
Nausea (feeling of having an urge to vomit): 1 person, 5.00%
Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract): 1 person, 5.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.00%
Diarrhea: 1 person, 5.00%
Diabetes: 1 person, 5.00%
Cystic Fibrosis Lung (fibrosis with cyst in the lung): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ivacaftor and have Pneumonia?

- Check whether Pneumonia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ivacaftor:

Ivacaftor (363 reports)

Pneumonia treatments and more:

Pneumonia (433,139 reports)

Browse all side effects of Ivacaftor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pneumonia:

Pneumonia (3,353 drugs)

Browse all the conditions that are associated with Pneumonia:

Pneumonia (4,681 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ivacaftor (the active ingredients of Ivacaftor) and Ivacaftor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.